[PHARMA] QoQ Annualized Quarter Result on 31-Mar-2013 [#1]

Announcement Date
15-May-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
31-Mar-2013 [#1]
Profit Trend
QoQ- 60.56%
YoY- -13.64%
Quarter Report
View:
Show?
Annualized Quarter Result
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Revenue 1,946,639 1,838,372 1,875,944 2,001,356 1,812,346 1,773,256 1,806,964 5.07%
PBT 92,997 79,986 93,058 147,696 103,313 132,088 141,146 -24.22%
Tax -36,236 -32,661 -30,410 -47,084 -40,108 -37,856 -50,870 -20.19%
NP 56,761 47,325 62,648 100,612 63,205 94,232 90,276 -26.54%
-
NP to SH 55,200 45,849 61,272 99,084 61,710 92,860 88,796 -27.09%
-
Tax Rate 38.96% 40.83% 32.68% 31.88% 38.82% 28.66% 36.04% -
Total Cost 1,889,878 1,791,046 1,813,296 1,900,744 1,749,141 1,679,024 1,716,688 6.59%
-
Net Worth 486,754 473,857 481,681 484,829 471,886 496,623 481,282 0.75%
Dividend
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Div 41,477 33,903 35,323 35,303 41,187 39,227 35,301 11.31%
Div Payout % 75.14% 73.95% 57.65% 35.63% 66.74% 42.24% 39.76% -
Equity
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Net Worth 486,754 473,857 481,681 484,829 471,886 496,623 481,282 0.75%
NOSH 258,911 258,938 258,968 117,676 117,677 117,683 117,672 68.92%
Ratio Analysis
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
NP Margin 2.92% 2.57% 3.34% 5.03% 3.49% 5.31% 5.00% -
ROE 11.34% 9.68% 12.72% 20.44% 13.08% 18.70% 18.45% -
Per Share
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
RPS 751.85 709.97 724.39 1,700.72 1,540.10 1,506.80 1,535.58 -37.79%
EPS 21.32 17.71 23.66 84.20 52.44 78.91 75.46 -56.84%
DPS 16.02 13.09 13.64 30.00 35.00 33.33 30.00 -34.10%
NAPS 1.88 1.83 1.86 4.12 4.01 4.22 4.09 -40.35%
Adjusted Per Share Value based on latest NOSH - 117,676
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
RPS 135.07 127.56 130.16 138.86 125.75 123.04 125.38 5.07%
EPS 3.83 3.18 4.25 6.87 4.28 6.44 6.16 -27.08%
DPS 2.88 2.35 2.45 2.45 2.86 2.72 2.45 11.34%
NAPS 0.3377 0.3288 0.3342 0.3364 0.3274 0.3446 0.3339 0.75%
Price Multiplier on Financial Quarter End Date
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Date 31/12/13 30/09/13 28/06/13 29/03/13 31/12/12 28/09/12 29/06/12 -
Price 4.45 4.82 4.49 8.26 8.10 7.55 10.18 -
P/RPS 0.59 0.68 0.62 0.49 0.53 0.50 0.66 -7.18%
P/EPS 20.87 27.22 18.98 9.81 15.45 9.57 13.49 33.65%
EY 4.79 3.67 5.27 10.19 6.47 10.45 7.41 -25.17%
DY 3.60 2.72 3.04 3.63 4.32 4.42 2.95 14.15%
P/NAPS 2.37 2.63 2.41 2.00 2.02 1.79 2.49 -3.23%
Price Multiplier on Announcement Date
31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 CAGR
Date 24/02/14 19/11/13 16/08/13 15/05/13 18/02/13 06/11/12 08/08/12 -
Price 4.29 4.72 4.66 9.26 7.80 8.25 8.83 -
P/RPS 0.57 0.66 0.64 0.54 0.51 0.55 0.58 -1.14%
P/EPS 20.12 26.66 19.70 11.00 14.87 10.46 11.70 43.39%
EY 4.97 3.75 5.08 9.09 6.72 9.56 8.55 -30.28%
DY 3.73 2.77 2.93 3.24 4.49 4.04 3.40 6.35%
P/NAPS 2.28 2.58 2.51 2.25 1.95 1.95 2.16 3.66%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment